The synaptic hypothesis of schizophrenia version III: a master mechanism
- PMID: 37041418
- PMCID: PMC10575788
- DOI: 10.1038/s41380-023-02043-w
The synaptic hypothesis of schizophrenia version III: a master mechanism
Abstract
The synaptic hypothesis of schizophrenia has been highly influential. However, new approaches mean there has been a step-change in the evidence available, and some tenets of earlier versions are not supported by recent findings. Here, we review normal synaptic development and evidence from structural and functional imaging and post-mortem studies that this is abnormal in people at risk and with schizophrenia. We then consider the mechanism that could underlie synaptic changes and update the hypothesis. Genome-wide association studies have identified a number of schizophrenia risk variants converging on pathways regulating synaptic elimination, formation and plasticity, including complement factors and microglial-mediated synaptic pruning. Induced pluripotent stem cell studies have demonstrated that patient-derived neurons show pre- and post-synaptic deficits, synaptic signalling alterations, and elevated, complement-dependent elimination of synaptic structures compared to control-derived lines. Preclinical data show that environmental risk factors linked to schizophrenia, such as stress and immune activation, can lead to synapse loss. Longitudinal MRI studies in patients, including in the prodrome, show divergent trajectories in grey matter volume and cortical thickness compared to controls, and PET imaging shows in vivo evidence for lower synaptic density in patients with schizophrenia. Based on this evidence, we propose version III of the synaptic hypothesis. This is a multi-hit model, whereby genetic and/or environmental risk factors render synapses vulnerable to excessive glia-mediated elimination triggered by stress during later neurodevelopment. We propose the loss of synapses disrupts pyramidal neuron function in the cortex to contribute to negative and cognitive symptoms and disinhibits projections to mesostriatal regions to contribute to dopamine overactivity and psychosis. It accounts for the typical onset of schizophrenia in adolescence/early adulthood, its major risk factors, and symptoms, and identifies potential synaptic, microglial and immune targets for treatment.
© 2023. The Author(s).
Conflict of interest statement
ODH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angelini, Autifony, Biogen, Boehringer Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan and was a part time employee of H Lundbeck A/s. ODH has a patent for the use of dopaminergic imaging. No other conflicts of interest were declared.
Figures





Similar articles
-
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization.Transl Psychiatry. 2017 Feb 7;7(2):e1024. doi: 10.1038/tp.2016.278. Transl Psychiatry. 2017. PMID: 28170004 Free PMC article. Review.
-
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance.Biol Psychiatry. 2022 Sep 15;92(6):501-513. doi: 10.1016/j.biopsych.2022.06.017. Epub 2022 Jun 22. Biol Psychiatry. 2022. PMID: 36008036 Review.
-
Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.Schizophr Res. 2018 May;195:206-214. doi: 10.1016/j.schres.2017.08.063. Epub 2017 Oct 12. Schizophr Res. 2018. PMID: 28893493 Free PMC article.
-
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes.Neuropsychopharmacology. 2023 Jan;48(1):151-167. doi: 10.1038/s41386-022-01426-x. Epub 2022 Sep 2. Neuropsychopharmacology. 2023. PMID: 36056106 Free PMC article. Review.
-
Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders.Curr Opin Psychiatry. 2021 May 1;34(3):222-227. doi: 10.1097/YCO.0000000000000696. Curr Opin Psychiatry. 2021. PMID: 33560023 Free PMC article. Review.
Cited by
-
Schizophrenia genomics: genetic complexity and functional insights.Nat Rev Neurosci. 2024 Sep;25(9):611-624. doi: 10.1038/s41583-024-00837-7. Epub 2024 Jul 19. Nat Rev Neurosci. 2024. PMID: 39030273 Review.
-
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise.Schizophr Res Cogn. 2024 Aug 29;38:100328. doi: 10.1016/j.scog.2024.100328. eCollection 2024 Dec. Schizophr Res Cogn. 2024. PMID: 39281320 Free PMC article.
-
Astrocytic-supplied cholesterol drives synaptic gene expression programs in developing neurons and downstream astrocytic transcriptional programs.bioRxiv [Preprint]. 2025 Jan 28:2025.01.28.635252. doi: 10.1101/2025.01.28.635252. bioRxiv. 2025. PMID: 39975161 Free PMC article. Preprint.
-
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation.Metabolites. 2025 Mar 5;15(3):176. doi: 10.3390/metabo15030176. Metabolites. 2025. PMID: 40137141 Free PMC article. Review.
-
Cortical gene expression architecture links healthy neurodevelopment to the imaging, transcriptomics and genetics of autism and schizophrenia.Nat Neurosci. 2024 Jun;27(6):1075-1086. doi: 10.1038/s41593-024-01624-4. Epub 2024 Apr 22. Nat Neurosci. 2024. PMID: 38649755 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical